{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:43:31Z","timestamp":1772585011936,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AA028297"],"award-info":[{"award-number":["K23AA028297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24AA027483"],"award-info":[{"award-number":["K24AA027483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AA027054"],"award-info":[{"award-number":["P50AA027054"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cld.2021.03.008","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T02:19:51Z","timestamp":1621995591000},"page":"645-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Peng-Sheng","family":"Ting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-9148","authenticated-orcid":false,"given":"Ahmet","family":"Gurakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetanjali","family":"Chander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/cld.172","article-title":"Histopathology of alcoholic liver disease","volume":"2","author":"Theise","year":"2013","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/acer.12956","article-title":"Alcoholic hepatitis: risk factors, pathogenesis, and approach to treatment","volume":"40","author":"Yeluru","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-018-0021-8","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2021.03.008_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.cld.2021.03.008_bib7","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"issue":"19","key":"10.1016\/j.cld.2021.03.008_bib9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/lt.25600","article-title":"Introducing the 2019 American Association for the Study of Liver Diseases Guidance on alcohol-associated liver disease","volume":"26","author":"Lucey","year":"2020","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cld.779","article-title":"Con: liver transplantation should not be performed in patients with acute alcoholic hepatitis","volume":"13","author":"Alsahhar","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.cld.2021.03.008_bib13","author":"SAMHSA"},{"key":"10.1016\/j.cld.2021.03.008_bib14","series-title":"Rebalancing the \u2018COVID-19 effect\u2019 on alcohol sales","year":"2020"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2021.03.008_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcoholic hepatitis","volume":"38","author":"Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cgh.2016.08.047","article-title":"Medical management of severe alcoholic hepatitis: expert review from the clinical practice updates committee of the AGA institute","volume":"15","author":"Mitchell","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2021.03.008_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1155\/2012\/945707","article-title":"A\u00a0meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis","volume":"26","author":"Antar","year":"2012","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States--A single-center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jamcollsurg.2017.12.044","article-title":"Liver transplantation for severe alcoholic hepatitis, updated lessons from the world's largest series","volume":"226","author":"Weeks","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2021.03.008_bib23","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.transproceed.2018.08.057","article-title":"Liver transplantation for severe alcoholic hepatitis: report of a single center pilot program","volume":"50","author":"Sundaram","year":"2018","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2017.11.027","article-title":"Early liver transplantation for alcoholic hepatitis: ready for primetime?","volume":"68","author":"Kubiliun","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2019.04.012","article-title":"Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis","volume":"157","author":"Lee","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.gastro.2018.06.096","article-title":"Early liver transplantation for alcoholic hepatitis","volume":"156","author":"Solga","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.5604\/01.3001.0012.3134","article-title":"Controversies in early liver transplantation for severe alcoholic hepatitis","volume":"17","author":"Wu","year":"2018","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/ajt.16143","article-title":"Liver transplantation for alcoholic hepatitis in the United States: excellent outcomes with profound temporal and geographic variation in frequency","volume":"21","author":"Cotter","year":"2021","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/lt.25681","article-title":"Meeting report: the Dallas consensus conference on liver transplantation for alcohol associated hepatitis","volume":"26","author":"Asrani","year":"2020","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jlts.2003.50009","article-title":"Longitudinal assessment of mortality risk among candidates for liver transplantation","volume":"9","author":"Merion","year":"2003","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2021.03.008_bib32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/lt.23762","article-title":"Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis","volume":"19","author":"Rice","year":"2013","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2021.03.008_bib33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","author":"Dumortier","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/lt.21278","article-title":"Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs","volume":"14","author":"Dew","year":"2008","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cld.696","article-title":"Risk factors, scoring systems, and interventions for alcohol relapse after liver transplantation for alcoholic liver disease","volume":"11","author":"Lim","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"9","key":"10.1016\/j.cld.2021.03.008_bib36","doi-asserted-by":"crossref","first-page":"e14003","DOI":"10.1111\/ctr.14003","article-title":"Predicting harmful alcohol relapse after liver transplant: the HALT score","volume":"34","author":"Satapathy","year":"2020","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib37","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/hep.30478","article-title":"Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000001831","article-title":"Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis","volume":"265","author":"Lee","year":"2017","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.cld.2021.03.008_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.15288\/jsa.1993.54.645","article-title":"Descriptive and predictive validity of a high-risk alcoholism relapse model","volume":"54","author":"Yates","year":"1993","journal-title":"J\u00a0Stud Alcohol"},{"issue":"11","key":"10.1016\/j.cld.2021.03.008_bib40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/archinte.167.11.1183","article-title":"A\u00a0simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years","volume":"167","author":"De Gottardi","year":"2007","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7182\/pit2013604","article-title":"The alcohol relapse risk assessment: a scoring system to predict the risk of relapse to any alcohol use after liver transplant","volume":"23","author":"Rodrigue","year":"2013","journal-title":"Prog Transplant"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psym.2011.12.012","article-title":"The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates","volume":"53","author":"Maldonado","year":"2012","journal-title":"Psychosomatics"},{"issue":"9","key":"10.1016\/j.cld.2021.03.008_bib43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/PSY.0000000000000241","article-title":"The Stanford Integrated Psychosocial Assessment for Transplantation: a prospective study of medical and psychosocial outcomes","volume":"77","author":"Maldonado","year":"2015","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib44","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(92)91737-O","article-title":"Selection for and outcome of liver transplantation in alcoholic liver disease","volume":"102","author":"Lucey","year":"1992","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/hep.510250526","article-title":"Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study","volume":"25","author":"Lucey","year":"1997","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.23596","article-title":"Assessing the drinking status of liver transplant patients with alcoholic liver disease","volume":"19","author":"Allen","year":"2013","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2021.03.008_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/tri.12949","article-title":"Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study","volume":"30","author":"Andresen-Streichert","year":"2017","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.cld.2021.03.008_bib49","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.ALC.0000139815.89794.BE","article-title":"A\u00a0review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels","volume":"28","author":"Fleming","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"6 Suppl","key":"10.1016\/j.cld.2021.03.008_bib51","first-page":"5S","article-title":"Conventional and coming laboratory markers of alcoholism and heavy drinking","volume":"10","author":"Salaspuro","year":"1986","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib52","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.24596","article-title":"Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption","volume":"54","author":"Staufer","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.cld.2021.03.008_bib54","article-title":"Opioid antagonists for alcohol dependence","author":"Rosner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2021.03.008_bib55","series-title":"Alkermes. Vivitrol (naltrexone) [package insert]","year":"2010"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","article-title":"State-of-the-art behavioral and pharmacological treatments for alcohol use disorder","volume":"45","author":"Ray","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"10.1016\/j.cld.2021.03.008_bib57","article-title":"Acamprosate for alcohol dependence","author":"Rosner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.cld.2021.03.008_bib58","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.cld.2021.03.008_bib60","series-title":"Clinical and research information on drug-induced liver injury","author":"LiverTox","year":"2018"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib61","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib62","article-title":"Anticonvulsants for alcohol dependence","author":"Pani","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.cld.2021.03.008_bib64","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2021.03.008_bib66","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/add.14191","article-title":"Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis","volume":"113","author":"Rose","year":"2018","journal-title":"Addiction"},{"issue":"9603","key":"10.1016\/j.cld.2021.03.008_bib67","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cld.2021.03.008_bib68","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/pds.4635","article-title":"Risk of hospitalisation and death related to baclofen for alcohol use disorders: comparison with Nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France","volume":"27","author":"Chaignot","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cld.2021.03.008_bib69","series-title":"Clinical and research information on drug-induced liver injury","author":"LiverTox","year":"2020"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0035-1565184","article-title":"Comparing Nalmefene and Naltrexone in alcohol dependence: are there any differences? Results from an indirect meta-analysis","volume":"49","author":"Soyka","year":"2016","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"10.1016\/j.cld.2021.03.008_bib71","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1517\/13543784.2010.522990","article-title":"Nalmefene for treatment of alcohol dependence","volume":"19","author":"Soyka","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib72","doi-asserted-by":"crossref","first-page":"19r12924","DOI":"10.4088\/JCP.19r12924","article-title":"The impact of varenicline on alcohol consumption in subjects with alcohol use disorders: systematic review and meta-analyses","volume":"81","author":"Gandhi","year":"2020","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/jcp.0b013e3181602fd4","article-title":"A\u00a0randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence","volume":"28","author":"Anton","year":"2008","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib74","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.addbeh.2012.12.018","article-title":"A\u00a0pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil","volume":"38","author":"Correa Filho","year":"2013","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib75","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e3181db38bb","article-title":"Placebo-controlled trial of zonisamide for the treatment of alcohol dependence","volume":"30","author":"Arias","year":"2010","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.cld.2021.03.008_bib76","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation","volume":"10","author":"DiMartini","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cld.854","article-title":"Behavioral treatment for patients with alcohol-related liver disease: a primer for hepatologists","volume":"15","author":"Ting","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"10","key":"10.1016\/j.cld.2021.03.008_bib78","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1111\/ajt.15569","article-title":"A\u00a0review of behavioral alcohol interventions for transplant candidates and recipients with alcohol-related liver disease","volume":"19","author":"Schlagintweit","year":"2019","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib79","doi-asserted-by":"crossref","first-page":"516","DOI":"10.15288\/jsad.2009.70.516","article-title":"Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials","volume":"70","author":"Magill","year":"2009","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"12","key":"10.1016\/j.cld.2021.03.008_bib80","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1037\/ccp0000447","article-title":"A\u00a0meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: treatment efficacy by contrast condition","volume":"87","author":"Magill","year":"2019","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"5","key":"10.1016\/j.cld.2021.03.008_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.22259","article-title":"A\u00a0randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation","volume":"17","author":"Weinrieb","year":"2011","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2021.03.008_bib82","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0749-3797(00)00254-3","article-title":"Motivational interviewing in health care settings. Opportunities and limitations","volume":"20","author":"Emmons","year":"2001","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/alcalc\/agl016","article-title":"The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review","volume":"41","author":"Vasilaki","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cld.2021.03.008_bib84","series-title":"Enhancing motivation for change in substance abuse treatment","author":"Center for Substance Abuse Treatment","year":"1999"},{"key":"10.1016\/j.cld.2021.03.008_bib85","series-title":"Planning and implementing screening and brief intervention for risky alcohol use: a step-by-step guide for primary care practices","author":"Centers for Disease Control and Prevention","year":"2014"},{"issue":"18","key":"10.1016\/j.cld.2021.03.008_bib86","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.2018.16789","article-title":"Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US preventive services task force recommendation statement","volume":"320","author":"U.S.P.S.T.F.","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib87","first-page":"350","article-title":"The role of mutual-help groups in extending the framework of treatment","volume":"33","author":"Kelly","year":"2011","journal-title":"Alcohol Res Health"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib88","article-title":"Alcoholics anonymous and other 12-step programs for alcohol use disorder","author":"Kelly","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.cld.2021.03.008_bib90","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/152692480501500406","article-title":"Liver transplant recipients' first year of posttransplant recovery: a longitudinal study","volume":"15","author":"Jones","year":"2005","journal-title":"Prog Transplant"},{"issue":"3","key":"10.1016\/j.cld.2021.03.008_bib91","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.tp.0000269797.41202.79","article-title":"The financial burden of transplantation: a single-center survey of liver and kidney transplant recipients","volume":"84","author":"Rodrigue","year":"2007","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2021.03.008_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2021.03.008_bib93","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:17Z","timestamp":1761069557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326121000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1089326121000325"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2021.03.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2021.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}